Nanobiotix Sa - Adr share price today

(NBTX)

Nanobiotix Sa - Adr share price is $3.1 & ₹263.43 as on 21 Dec 2024, 2.30 'hrs' IST

$3.1

▲

-0.18

(-5.49%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Nanobiotix Sa - Adr share price in Dollar and Rupees. Guide to invest in Nanobiotix Sa - Adr from India. Also see the sentimental analysis on Indian investors investing in Nanobiotix Sa - Adr. Get details on the Indian mutual funds that are investing in Nanobiotix Sa - Adr. Get Analyst recommendations and forecasts along with all the Nanobiotix Sa - Adr's financials.

Nanobiotix Sa - Adr share price movements

Today's Low: $3.10
Today's High: $3.39
$3.10
0.0%
Downside
Day's Volatility :8.55%
Upside
8.55%
52 Weeks Low: $2.76
52 Weeks High: $8.96
$3.10
10.97%
Downside
52 Weeks Volatility :69.2%
Upside
65.41%

Nanobiotix Sa - Adr Returns

Period	Nanobiotix Sa - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-37.12%	-11.1%	0.0%
6 Months	-28.9%	-6.0%	0.0%
1 Year	-52.96%	2.7%	0.0%
3 Years	-60.96%	0.6%	-19.7%

Nanobiotix Sa - Adr Key Statistics

in dollars & INR

Previous Close	$3.28
Open	$3.39
Today's High	$3.39
Today's Low	$3.1
Market Capitalization	$173.1M
Today's Volume	$219.3K
52 Week High	$8.962
52 Week Low	$2.76
Revenue TTM	$42.2M
EBITDA	$-22.3M
Earnings Per Share (EPS)	$-0.78
Profit Margin	-79.31%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-198.69%

How to invest in Nanobiotix Sa - Adr from India?

It is very easy for Indian residents to invest directly in Nanobiotix Sa - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nanobiotix Sa - Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nanobiotix Sa - Adr or NBTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nanobiotix Sa - Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nanobiotix Sa - Adr shares which would translate to 0.274 fractional shares of Nanobiotix Sa - Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Nanobiotix Sa - Adr, in just a few clicks!

Returns in Nanobiotix Sa - Adr for Indian investors in Rupees

Investment Value

₹1,00,000

Nanobiotix Sa - Adr investment value today

Current value as on today

₹1,55,155

Returns

₹55,155

(+55.16%)

Returns from Nanobiotix Sa - Adr Stock

₹52,959 (false-52.96%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Nanobiotix Sa - Adr

145%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Nanobiotix Sa - Adr on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 145% more investors are searching Nanobiotix Sa - Adr in the last 30 days versus the previous period.

Global Institutional Holdings in Nanobiotix Sa - Adr

Johnson & Johnson
11.86%
Perceptive Advisors LLC
1.17%
BlackRock Inc
0.50%
Citigroup Inc
0.01%
UBS Group AG
0.01%
GAMMA Investing LLC
0.01%

Analyst Recommendation on Nanobiotix Sa - Adr

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Nanobiotix Sa - Adr(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Nanobiotix Sa - Adr

What analysts predicted

Upside of 233.7%

Current:

$3.10

Target:

$10.34

Insights on Nanobiotix Sa - Adr

Price Movement
In the last 1 month, NBTX stock has moved down by -19.1%
Decreasing Revenue
Revenue is down for the last 3 quarters, 16.45M → 4.64M (in $), with an average decrease of 35.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -5.80M → -10.93M (in $), with an average decrease of 44.3% per quarter
NBTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 95.1%
NBTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 84.5%
Price to Sales
ForNBTX every $1 of sales, investors are willing to pay $3.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Nanobiotix Sa - Adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$132.0K	↓ 53.96%
Net Income	$-34.0M	↑ 14.35%
Net Profit Margin	-25.8K%	↓ 15396.79%

	FY19	Y/Y Change
Revenue	$75.6K	↓ 41.38%
Net Income	$-56.6M	↑ 70.31%
Net Profit Margin	-74.9K%	↓ 49102.59%

	FY20	Y/Y Change
Revenue	$60.8K	↓ 26.47%
Net Income	$-40.9M	↓ 33.96%
Net Profit Margin	-67.2K%	↑ 7629.0%

	FY21	Y/Y Change
Revenue	$11.3K	↓ 80.0%
Net Income	$-53.1M	↑ 39.8%
Net Profit Margin	-470.0K%	↓ 402794.0%

	FY22	Y/Y Change
Revenue	$5.1M	↑ 47660.0%
Net Income	$-60.4M	↑ 21.36%
Net Profit Margin	-1.2K%	↑ 468845.63%

	FY23	Y/Y Change
Revenue	$32.8M	↑ 529.36%
Net Income	$-43.3M	↓ 30.4%
Net Profit Margin	-132.08%	↑ 1062.29%

	Q1 FY23	Q/Q Change
Revenue	$1.8M	-
Net Income	$-15.0M	-
Net Profit Margin	-853.29%	-

	Q2 FY23	Q/Q Change
Revenue	$1.8M	↑ 0.0%
Net Income	$-30.5M	↑ 100.0%
Net Profit Margin	-1.7K%	↓ 853.3%

	Q3 FY23	Q/Q Change
Revenue	$16.5M	↑ 899.54%
Net Income	$-5.8M	↓ 79.36%
Net Profit Margin	-35.25%	↑ 1671.34%

	Q1 FY24	Q/Q Change
Revenue	$4.6M	↓ 71.78%
Net Income	$-10.9M	↑ 88.54%
Net Profit Margin	-235.46%	↓ 200.21%

	Q2 FY24	Q/Q Change
Revenue	$4.6M	↑ 0.0%
Net Income	$-10.9M	↑ 0.0%
Net Profit Margin	-235.46%	↑ 0.0%

	FY18	Y/Y Change
Profit	$132.0K	↓ 53.96%

	FY19	Y/Y Change
Profit	$75.6K	↓ 41.38%

	FY20	Y/Y Change
Profit	$60.8K	↓ 26.47%

	FY21	Y/Y Change
Profit	$11.3K	↓ 80.0%

	FY22	Y/Y Change
Profit	$4.0M	↑ 37810.0%

	FY23	Y/Y Change
Profit	$32.8M	↑ 692.88%

	Q1 FY23	Q/Q Change
Profit	$1.8M	-

	Q2 FY23	Q/Q Change
Profit	$983.3K	↓ 44.94%

	Q3 FY23	Q/Q Change
Profit	$16.5M	↑ 1715.5%

	Q1 FY24	Q/Q Change
Profit	$4.6M	↓ 71.78%

	Q2 FY24	Q/Q Change
Profit	$4.6M	↑ 0.0%

	FY18	Y/Y Change
Operating Cash Flow	$-29.6M	↑ 23.55%
Investing Cash Flow	$80.8K	↓ 104.54%
Financing Cash Flow	$16.9M	↓ 69.4%

	FY19	Y/Y Change
Operating Cash Flow	$-45.7M	↑ 58.43%
Investing Cash Flow	$-1.6M	↓ 2154.93%
Financing Cash Flow	$46.1M	↑ 179.39%

	FY20	Y/Y Change
Operating Cash Flow	$-33.5M	↓ 33.11%
Investing Cash Flow	$-136.2K	↓ 92.32%
Financing Cash Flow	$135.9M	↑ 169.39%

	FY21	Y/Y Change
Operating Cash Flow	$-33.8M	↑ 8.48%
Investing Cash Flow	$-273.6K	↑ 116.07%
Financing Cash Flow	$-5.9M	↓ 104.63%

	FY22	Y/Y Change
Operating Cash Flow	$-39.3M	↑ 24.21%
Investing Cash Flow	$146.0K	↓ 157.02%
Financing Cash Flow	$-6.0M	↑ 9.09%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-10.4M	↑ 0.01%
Investing Cash Flow	$45.0K	↑ 0.0%
Financing Cash Flow	$-1.1M	↑ 0.0%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-9.2M	↓ 11.8%
Investing Cash Flow	$-175.0K	↓ 484.71%
Financing Cash Flow	$-1.1M	↓ 0.33%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-19.1M	↑ 103.48%
Investing Cash Flow	$-177.4K	↑ 0.0%
Financing Cash Flow	$-2.0M	↑ 71.84%

Nanobiotix Sa - Adr Technicals Summary

Sell

Neutral

Buy

Nanobiotix Sa - Adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nanobiotix Sa - Adr Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nanobiotix Sa - Adr	-19.06%	-28.9%	-52.96%	-60.96%	-78.59%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nanobiotix Sa - Adr	NA	NA	NA	-1.17	-1.99	-0.22	NA	-0.46
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nanobiotix Sa - Adr	Buy	$173.1M	-78.59%	NA	-79.31%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Nanobiotix Sa - Adr

nanobiotix (euronext: nano / isin: fr0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. the company’s first-in-class, proprietary technology, nanoxray, enhances radiotherapy energy with a view to providing a new, more efficient treatment for cancer patients. nanoxray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration. nbtxr3 is being evaluated in: soft tissue sarcoma (sts), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). additionally, head and neck cancer and rectal cancer trials led by nanobiotix’s taiwanese partner, pharmaengine, are underway in the asia pacific region. the company started a new preclinical research program in immuno-oncology with its lea

Organization	Nanobiotix Sa - Adr
Employees	110
CEO	Mr. Laurent Levy Ph.D.
Industry	Healthcare

Management People of Nanobiotix Sa - Adr

Name	Title
Mr. Laurent Levy Ph.D.	Co-Founder, President of the Executive Board & CEO
Mr. Bart Van Rhijn	Chief Financial & Business Officer and Member of Executive Board
Ms. Anne-Juliette Hermant M.A.	Chief People Officer & Member of Executive Board
Dr. Louis Kayitalire M.D.	Chief Medical Officer
Mr. Earl J. Bergey Ph.d.	Co-Founder
Mr. Craig West CFA	Senior Vice President of Investor Relations
Mr. Brandon Owens	VP of Strategic Marketing & Corporate Communication
Ms. Margaret Galluzzi	VP & Global Head of Clinical Operations
Dr. Leonard A. Farber M.D.	Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

Important FAQs about investing in Nanobiotix Sa - Adr from India :

What is Nanobiotix Sa - Adr share price today?

Nanobiotix Sa - Adr share price today stands at $3.10, Open: $3.39 ; Previous Close: $3.28 ; High: $3.39 ; Low: $3.10 ; 52 Week High: $8.96 ; 52 Week Low: $2.76. The stock opens at $3.39, after a previous close of $3.28. The stock reached a daily high of $3.39 and a low of $3.10, with a 52-week high of $8.96 and a 52-week low of $2.76.

Can Indians buy Nanobiotix Sa - Adr shares?

Yes, Indians can invest in the Nanobiotix Sa - Adr (NBTX) from India.

With INDmoney, you can buy Nanobiotix Sa - Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Nanobiotix Sa - Adr at zero transaction cost.

How can I buy Nanobiotix Sa - Adr shares from India?

It is very easy to buy Nanobiotix Sa - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nanobiotix Sa - Adr be purchased?

Yes, you can buy fractional shares of Nanobiotix Sa - Adr with INDmoney app.

What are the documents required to start investing in Nanobiotix Sa - Adr stocks?

To start investing in Nanobiotix Sa - Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.